DENALI THERAPEUTICS INC

Ticker: DNLI CUSIP: 24823R105 Class: Common Stock

XPONANCE, INC.'s Holding History (CIK: 0001637541)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 10,497 Value ($000) $173 Avg Close $16.88 Range $13.75 - $20.61

Q3 2025

Shares 10,400 Value ($000) $151 Avg Close $14.37 Range $12.58 - $16.20

Q2 2025

Shares 10,352 Value ($000) $145 Avg Close $14.07 Range $10.57 - $16.97

Q3 2024

Shares 8,135 Value ($000) $237 Avg Close $24.79 Range $19.74 - $32.13

Q2 2023

Shares 6,963 Value ($000) $205 Avg Close $28.12 Range $22.72 - $33.31

Q3 2021

Shares 4,315 Value ($000) $218 Avg Close $56.36 Range $47.02 - $79.50

Q2 2021

Shares 5,014 Value ($000) $393 Avg Close $61.86 Range $49.20 - $79.70

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	10,497	$173	$16.88	$13.75 - $20.61
Q3 2025	10,400	$151	$14.37	$12.58 - $16.20
Q2 2025	10,352	$145	$14.07	$10.57 - $16.97
Q3 2024	8,135	$237	$24.79	$19.74 - $32.13
Q2 2023	6,963	$205	$28.12	$22.72 - $33.31
Q3 2021	4,315	$218	$56.36	$47.02 - $79.50
Q2 2021	5,014	$393	$61.86	$49.20 - $79.70